创新-话题@MedSci

#创新#

1015篇内容 | 8058人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1285673, encodeId=facf12856e363, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=西安杨森两款艾滋病创新药物恩临和普泽力宣布在华上市, objectType=article, longId=154280, objectId=28011542800a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28011542800a, replyNumber=0, likeNumber=102, createdTime=2018-11-25, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28011542800a, moduleTitle=西安杨森两款艾滋病创新药物恩临和普泽力宣布在华上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28011542800a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285672, encodeId=967612856e259, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=上海5大健康服务业园区集中亮相，聚焦医疗创新与健康服务, objectType=article, longId=154273, objectId=2e3e1542e391, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e3e1542e391, replyNumber=0, likeNumber=75, createdTime=2018-11-25, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e3e1542e391, moduleTitle=上海5大健康服务业园区集中亮相，聚焦医疗创新与健康服务, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e3e1542e391)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285671, encodeId=311912856e1d6, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=专访︱国产创新药将迎黄金十年：化学家马大为的“合成配方”, objectType=article, longId=154269, objectId=298e1542693b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=298e1542693b, replyNumber=0, likeNumber=54, createdTime=2018-11-25, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=298e1542693b, moduleTitle=专访︱国产创新药将迎黄金十年：化学家马大为的“合成配方”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=298e1542693b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285670, encodeId=2e4f12856e0a4, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=拜耳创新解决方案助力提升蔬果品质，带来更高收益, objectType=article, longId=153821, objectId=303a15382185, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=303a15382185, replyNumber=0, likeNumber=57, createdTime=2018-11-19, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=303a15382185, moduleTitle=拜耳创新解决方案助力提升蔬果品质，带来更高收益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=303a15382185)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285669, encodeId=514a1285669ff, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=天境生物与MorphoSys就肿瘤创新生物药 MOR210 开发达成战略合作, objectType=article, longId=153699, objectId=8bc5153699c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bc5153699c6, replyNumber=0, likeNumber=57, createdTime=2018-11-18, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bc5153699c6, moduleTitle=天境生物与MorphoSys就肿瘤创新生物药 MOR210 开发达成战略合作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bc5153699c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285668, encodeId=f8a612856685a, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=数问生物项目获得2018第七届中国创新创业大赛优秀奖, objectType=article, longId=153696, objectId=c12915369660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c12915369660, replyNumber=0, likeNumber=58, createdTime=2018-11-18, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c12915369660, moduleTitle=数问生物项目获得2018第七届中国创新创业大赛优秀奖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c12915369660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285667, encodeId=6937128566e42, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=盘点Top10医学创新，或将改变2019年医学实践, objectType=article, longId=153458, objectId=834715345819, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=834715345819, replyNumber=0, likeNumber=61, createdTime=2018-11-15, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=834715345819, moduleTitle=盘点Top10医学创新，或将改变2019年医学实践, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=834715345819)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285666, encodeId=3e30128566638, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=曼彻斯特大学学者分享中英医疗健康领域改革创新, objectType=article, longId=153349, objectId=2734153349b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2734153349b1, replyNumber=0, likeNumber=55, createdTime=2018-11-14, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2734153349b1, moduleTitle=曼彻斯特大学学者分享中英医疗健康领域改革创新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2734153349b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285665, encodeId=faea12856658b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=上海推“鼓励药械创新32条”建全球领先生物医药创研高地, objectType=article, longId=152996, objectId=e6e015299672, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6e015299672, replyNumber=0, likeNumber=90, createdTime=2018-11-09, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6e015299672, moduleTitle=上海推“鼓励药械创新32条”建全球领先生物医药创研高地, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6e015299672)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285664, encodeId=2991128566445, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=阿斯利康亮相首届进博会 -- 引进全球新药，加码中国创新, objectType=article, longId=152907, objectId=20b715290ef2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20b715290ef2, replyNumber=0, likeNumber=0, createdTime=2018-11-08, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20b715290ef2, moduleTitle=阿斯利康亮相首届进博会 -- 引进全球新药，加码中国创新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20b715290ef2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285663, encodeId=2e64128566325, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=药监局：创新医疗器械特别审查程序正式发布, objectType=article, longId=152890, objectId=07af15289023, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07af15289023, replyNumber=0, likeNumber=61, createdTime=2018-11-08, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07af15289023, moduleTitle=药监局：创新医疗器械特别审查程序正式发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07af15289023)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285662, encodeId=697e1285662b6, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=拜耳通过进博会平台展示创新产品及解决方案, objectType=article, longId=152852, objectId=05271528528b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05271528528b, replyNumber=0, likeNumber=65, createdTime=2018-11-07, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05271528528b, moduleTitle=拜耳通过进博会平台展示创新产品及解决方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05271528528b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285661, encodeId=115e1285661f9, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=北大医疗波士顿创新中心成立, objectType=article, longId=152850, objectId=d550152850e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d550152850e6, replyNumber=0, likeNumber=65, createdTime=2018-11-07, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d550152850e6, moduleTitle=北大医疗波士顿创新中心成立, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d550152850e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285660, encodeId=12861285660d0, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=全球医药创新的中国“秀场”, objectType=article, longId=152837, objectId=950015283e16, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=950015283e16, replyNumber=0, likeNumber=62, createdTime=2018-11-07, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=950015283e16, moduleTitle=全球医药创新的中国“秀场”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=950015283e16)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285659, encodeId=405812856596c, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=优时比创新疗法在中国上市，为帕金森病患者带来新希望, objectType=article, longId=152789, objectId=fe2a152e89ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe2a152e89ff, replyNumber=0, likeNumber=72, createdTime=2018-11-07, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe2a152e89ff, moduleTitle=优时比创新疗法在中国上市，为帕金森病患者带来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe2a152e89ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285658, encodeId=17cf128565866, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=中国极重度脊柱畸形病例创新手术引关注, objectType=article, longId=152782, objectId=7ff1152e8266, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ff1152e8266, replyNumber=0, likeNumber=72, createdTime=2018-11-06, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ff1152e8266, moduleTitle=中国极重度脊柱畸形病例创新手术引关注, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ff1152e8266)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285657, encodeId=39cd128565eb5, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=美国强生旗下西安杨森总裁：中国正从制药大国向创新大国改变, objectType=article, longId=152754, objectId=31a7152e5491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31a7152e5491, replyNumber=0, likeNumber=49, createdTime=2018-11-06, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31a7152e5491, moduleTitle=美国强生旗下西安杨森总裁：中国正从制药大国向创新大国改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31a7152e5491)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285656, encodeId=f10912856560c, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=陕西鼓励药品医疗器械创新：仿制新药优先纳入医保, objectType=article, longId=152735, objectId=c61d152e35df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c61d152e35df, replyNumber=0, likeNumber=80, createdTime=2018-11-05, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c61d152e35df, moduleTitle=陕西鼓励药品医疗器械创新：仿制新药优先纳入医保, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c61d152e35df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285655, encodeId=187412856554c, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=天境生物全球rhIL-7肿瘤创新药喜获中国临床研究批件, objectType=article, longId=152705, objectId=3652152e05d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3652152e05d2, replyNumber=0, likeNumber=57, createdTime=2018-11-05, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3652152e05d2, moduleTitle=天境生物全球rhIL-7肿瘤创新药喜获中国临床研究批件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3652152e05d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285654, encodeId=8437128565433, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=中国生物创新药发展现状, objectType=article, longId=152515, objectId=832015251504, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=832015251504, replyNumber=0, likeNumber=0, createdTime=2018-11-03, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=832015251504, moduleTitle=中国生物创新药发展现状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=832015251504)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

创新

2020-05-29

lilianxiang (审核中...)

前往app查看评论内容

#创新#

西安杨森两款艾滋病创新药物恩临和普泽力宣布在华上市

2018-11-25

lilianxiang (审核中...)

前往app查看评论内容

#创新#

上海5大健康服务业园区集中亮相，聚焦医疗创新与健康服务

2018-11-25

lilianxiang (审核中...)

前往app查看评论内容

#创新#

专访︱国产创新药将迎黄金十年：化学家马大为的“合成配方”

2018-11-25

lilianxiang (审核中...)

前往app查看评论内容

#创新#

拜耳创新解决方案助力提升蔬果品质，带来更高收益

2018-11-19

lilianxiang (审核中...)

前往app查看评论内容

#创新#

天境生物与MorphoSys就肿瘤创新生物药 MOR210 开发达成战略合作

2018-11-18

lilianxiang (审核中...)

前往app查看评论内容

#创新#

数问生物项目获得2018第七届中国创新创业大赛优秀奖

2018-11-18

lilianxiang (审核中...)

前往app查看评论内容

#创新#

盘点Top10医学创新，或将改变2019年医学实践

2018-11-15

lilianxiang (审核中...)

前往app查看评论内容

#创新#

曼彻斯特大学学者分享中英医疗健康领域改革创新

2018-11-14

lilianxiang (审核中...)

前往app查看评论内容

#创新#

上海推“鼓励药械创新32条”建全球领先生物医药创研高地

2018-11-09

lilianxiang (审核中...)

前往app查看评论内容

#创新#

阿斯利康亮相首届进博会 -- 引进全球新药，加码中国创新

2018-11-08

lilianxiang (审核中...)

前往app查看评论内容

#创新#

药监局：创新医疗器械特别审查程序正式发布

2018-11-08

lilianxiang (审核中...)

前往app查看评论内容

#创新#

拜耳通过进博会平台展示创新产品及解决方案

2018-11-07

lilianxiang (审核中...)

前往app查看评论内容

#创新#

北大医疗波士顿创新中心成立

2018-11-07

lilianxiang (审核中...)

前往app查看评论内容

#创新#

全球医药创新的中国“秀场”

2018-11-07

lilianxiang (审核中...)

前往app查看评论内容

#创新#

优时比创新疗法在中国上市，为帕金森病患者带来新希望

2018-11-07

lilianxiang (审核中...)

前往app查看评论内容

#创新#

中国极重度脊柱畸形病例创新手术引关注

2018-11-06

lilianxiang (审核中...)

前往app查看评论内容

#创新#

美国强生旗下西安杨森总裁：中国正从制药大国向创新大国改变

2018-11-06

lilianxiang (审核中...)

前往app查看评论内容

#创新#

陕西鼓励药品医疗器械创新：仿制新药优先纳入医保

2018-11-05

lilianxiang (审核中...)

前往app查看评论内容

#创新#

天境生物全球rhIL-7肿瘤创新药喜获中国临床研究批件

2018-11-05

lilianxiang (审核中...)

前往app查看评论内容

#创新#

中国生物创新药发展现状

2018-11-03

科室
- - 订阅+
  - 更多科室
工具
服务